• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国艰难梭菌两种核糖体分型的合并感染:一例报告

Coinfection with 2 Clostridium difficile ribotypes in China: A case report.

作者信息

Wang Liqian, Luo Yun, Huang Chen, Wu Shenghai, Ye Julian, Song Xiaojun, Jin Dazhi, Wang Xianjun

机构信息

Department of Laboratory Medicine, Zhejiang Chinese Medical University Affiliated Hangzhou First Hospital Department of Microbiology, Zhejiang Provincial Center for Disease Control and Prevention Department of Laboratory Medicine, Hangzhou First Hospital, Huansha road, Hangzhou, Zhejiang, China.

出版信息

Medicine (Baltimore). 2018 Mar;97(13):e9946. doi: 10.1097/MD.0000000000009946.

DOI:10.1097/MD.0000000000009946
PMID:29595702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5895390/
Abstract

RATIONALE

Clostridium difficile infections (CDIs) have been reported in China, but detailed clinical symptoms of coinfection by 2 C difficile ribotypes have not been documented.

PATIENTS CONCERNS

An 83-year-old male with a 10-day history of diarrhea and urinary tract infection was admitted to the hospital. The patient had received ofloxacin for several days, but his clinical response was poor. Laboratory workup revealed high white blood cell (WBC), serum creatinine (Scr), and C-reactive protein (CRP) levels. Based on these abnormal lab results, rapid detection of glutamate dehydrogenase and toxin A and B was performed.

DIAGNOSIS

Severe CDI.

INTERVENTIONS

Oral vancomycin was administered for 8 days.

OUTCOMES

Diarrhea symptoms improved and C difficile culture was negative after oral vancomycin administration for 8 days. Clostridium difficile was isolated from 3 consecutive stool samples at 2-day intervals because the patient was admitted to the hospital. Polymerase chain reaction ribotyping revealed ribotype (RT) 017 in the first 2 samples and RT 001 in the third sample. RT 017 caused significantly higher increases in the levels of WBC, Scr, and CRP than RT 001.

LESSONS

It is necessary to improve clinicians' awareness of CDI and reduce the severity of CDI caused by RT 017 in China.

摘要

原理

中国已报告艰难梭菌感染(CDIs),但两种艰难梭菌核糖型合并感染的详细临床症状尚无文献记载。

患者情况

一名83岁男性因腹泻和尿路感染10天入院。患者已接受氧氟沙星治疗数天,但临床反应不佳。实验室检查显示白细胞(WBC)、血清肌酐(Scr)和C反应蛋白(CRP)水平升高。基于这些异常实验室结果,进行了谷氨酸脱氢酶以及毒素A和B的快速检测。

诊断

严重艰难梭菌感染。

干预措施

口服万古霉素8天。

结果

口服万古霉素8天后腹泻症状改善,艰难梭菌培养结果为阴性。由于患者住院,每隔2天从连续3次粪便样本中分离出艰难梭菌。聚合酶链反应核糖分型显示前两个样本为核糖型(RT)017,第三个样本为RT 001。RT 017导致WBC、Scr和CRP水平升高的幅度明显高于RT 001。

经验教训

在中国,有必要提高临床医生对艰难梭菌感染的认识,并降低由RT 017引起的艰难梭菌感染的严重程度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f001/5895390/f81c406f9946/medi-97-e9946-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f001/5895390/f81c406f9946/medi-97-e9946-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f001/5895390/f81c406f9946/medi-97-e9946-g002.jpg

相似文献

1
Coinfection with 2 Clostridium difficile ribotypes in China: A case report.中国艰难梭菌两种核糖体分型的合并感染:一例报告
Medicine (Baltimore). 2018 Mar;97(13):e9946. doi: 10.1097/MD.0000000000009946.
2
Enhanced surveillance of Clostridium difficile infection occurring outside hospital, England, 2011 to 2013.强化监测英格兰地区 2011 至 2013 年发生在医院外的艰难梭菌感染。
Euro Surveill. 2016 Jul 21;21(29). doi: 10.2807/1560-7917.ES.2016.21.29.30295.
3
Clinical Characteristics and Treatment Outcomes of Clostridium difficile Infections by PCR Ribotype 017 and 018 Strains.PCR核糖体分型017和018菌株所致艰难梭菌感染的临床特征及治疗结果
PLoS One. 2016 Dec 21;11(12):e0168849. doi: 10.1371/journal.pone.0168849. eCollection 2016.
4
The association of a reduced susceptibility to moxifloxacin in causative Clostridium (Clostridioides) difficile strain with the clinical outcome of patients.导致艰难梭菌(艰难梭状芽孢杆菌)菌株对莫西沙星敏感性降低与患者临床结局的关系。
Antimicrob Resist Infect Control. 2020 Jun 30;9(1):98. doi: 10.1186/s13756-020-00765-y.
5
Comparative clinical outcomes evaluation of hospitalized patients infected with Clostridioides difficile ribotype 106 vs. other toxigenic strains.比较感染艰难梭菌 106 型和其他产毒株的住院患者的临床结局评估。
Anaerobe. 2021 Dec;72:102440. doi: 10.1016/j.anaerobe.2021.102440. Epub 2021 Aug 27.
6
Clinical characteristics of Clostridium difficile infection in hospitalized patients with antibiotic-associated diarrhea in a university hospital in China.中国某大学医院抗生素相关性腹泻住院患者艰难梭菌感染的临床特征
Eur J Clin Microbiol Infect Dis. 2014 Oct;33(10):1773-9. doi: 10.1007/s10096-014-2132-9. Epub 2014 May 13.
7
Toxigenic Clostridium difficile colonization among hospitalised adults; risk factors and impact on survival.住院成人中产毒艰难梭菌定植;危险因素及其对生存的影响。
J Infect. 2017 Jul;75(1):20-25. doi: 10.1016/j.jinf.2017.04.006. Epub 2017 Apr 21.
8
PCR ribotypes of across Texas from 2011 to 2018 including emergence of ribotype 255.2011 年至 2018 年期间,德克萨斯州的 255 型核糖体型的出现。
Emerg Microbes Infect. 2020 Feb 10;9(1):341-347. doi: 10.1080/22221751.2020.1721335. eCollection 2020.
9
Coinfection and Emergence of Rifamycin Resistance during a Recurrent Clostridium difficile Infection.艰难梭菌复发性感染期间的合并感染及利福霉素耐药性的出现
J Clin Microbiol. 2016 Nov;54(11):2689-2694. doi: 10.1128/JCM.01025-16. Epub 2016 Aug 24.
10
Use of modified PCR ribotyping for direct detection of Clostridium difficile ribotypes in stool samples.应用改良 PCR 核糖体分型技术直接检测粪便样本中的艰难梭菌核糖体分型。
J Clin Microbiol. 2011 Aug;49(8):3024-5. doi: 10.1128/JCM.01013-11. Epub 2011 Jun 1.

引用本文的文献

1
Genomic evolution and virulence association of sequence type 37 (ribotype 017) in China.中国序列型 37(核糖型 017)的基因组进化与毒力关联。
Emerg Microbes Infect. 2021 Dec;10(1):1331-1345. doi: 10.1080/22221751.2021.1943538.
2
Phylogenomics of 8,839 Clostridioides difficile genomes reveals recombination-driven evolution and diversification of toxin A and B.8839 株艰难梭菌基因组的系统发生基因组学研究揭示了毒素 A 和 B 的重组驱动进化和多样化。
PLoS Pathog. 2020 Dec 28;16(12):e1009181. doi: 10.1371/journal.ppat.1009181. eCollection 2020 Dec.

本文引用的文献

1
Molecular Epidemiology of Clostridium difficile Infection in Hospitalized Patients in Eastern China.中国东部住院患者艰难梭菌感染的分子流行病学
J Clin Microbiol. 2017 Mar;55(3):801-810. doi: 10.1128/JCM.01898-16. Epub 2016 Dec 14.
2
Clostridium difficile infection: epidemiology, diagnosis and understanding transmission.艰难梭菌感染:流行病学、诊断和传播途径的理解。
Nat Rev Gastroenterol Hepatol. 2016 Apr;13(4):206-16. doi: 10.1038/nrgastro.2016.25. Epub 2016 Mar 9.
3
The First Two Clostridium difficile Ribotype 027/ST1 Isolates Identified in Beijing, China-an Emerging Problem or a Neglected Threat?
在中国北京鉴定出的前两株艰难梭菌核糖体分型027/序列型1分离株——一个新出现的问题还是被忽视的威胁?
Sci Rep. 2016 Jan 7;6:18834. doi: 10.1038/srep18834.
4
Burden of Clostridium difficile infection in the United States.美国艰难梭菌感染的负担
N Engl J Med. 2015 Jun 11;372(24):2368-9. doi: 10.1056/NEJMc1505190.
5
A new type of toxin A-negative, toxin B-positive Clostridium difficile strain lacking a complete tcdA gene.一种新型的艰难梭菌菌株,该菌株毒素A阴性、毒素B阳性,且缺乏完整的tcdA基因。
J Clin Microbiol. 2015 Feb;53(2):692-5. doi: 10.1128/JCM.02211-14. Epub 2014 Nov 26.
6
The first case of severe Clostridium difficile ribotype 027 infection in Taiwan.台湾首例严重艰难梭菌核糖体分型027感染病例。
J Infect. 2015 Jan;70(1):98-101. doi: 10.1016/j.jinf.2014.08.003. Epub 2014 Aug 21.
7
Molecular epidemiology of Clostridium difficile in a tertiary hospital of China.中国一家三甲医院艰难梭菌的分子流行病学研究。
J Med Microbiol. 2014 Apr;63(Pt 4):562-569. doi: 10.1099/jmm.0.068668-0. Epub 2013 Dec 16.
8
Multilocus sequence typing (MLST) analysis of 104 Clostridium difficile strains isolated from China.对从中国分离的 104 株艰难梭菌的多位点序列分型(MLST)分析。
Epidemiol Infect. 2013 Jan;141(1):195-9. doi: 10.1017/S0950268812000453. Epub 2012 Apr 4.
9
Clostridium difficile infection in Europe: a hospital-based survey.欧洲艰难梭菌感染:一项基于医院的调查。
Lancet. 2011 Jan 1;377(9759):63-73. doi: 10.1016/S0140-6736(10)61266-4.
10
Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).艰难梭菌感染临床实践指南:美国医疗保健流行病学学会(SHEA)和美国传染病学会(IDSA)2010 年更新版。
Infect Control Hosp Epidemiol. 2010 May;31(5):431-55. doi: 10.1086/651706.